Di Marzio: Milan make decision on Kamada and Loftus-Cheek – the situation

By Isak Möller -

Before getting sacked, Paolo Maldini and Ricky Massara were in advanced talks with both Daichi Kamada and Ruben Loftus-Cheek. The new Milan management has now made a decision on these negotiations. 

According to Gianluca Di Marzio, as cited by our colleagues at SempreMilan.it, Milan have decided to move ahead with the Kamada negotiation. The attacking midfielder’s contract will expire at the end of the month and he would thus arrive on a free transfer, which the management likes a lot.

As for Loftus-Cheek, however, Milan have seemingly shelved that operation and it’s unlikely that they will make a new move for the Chelsea midfielder. Youri Tielemans appears to be the main target for that position, instead.

Yesterday, The Daily Telegraph reported that Milan had an agreement with Chelsea at £15m (€18m) for Loftus-Cheek. Now, however, the situation is very different and the Stamford Bridge side will likely have to find another suitor for the 27-year-old.

Tags AC Milan Chelsea Daichi Kamada Ruben Loftus-Cheek

10 Comments

  1. Looking forward to Kamada joining Milan and it makes sense also if we could land Tielemans instead of RLC(injury prone). Also no transfer fee involved.

  2. Way to go Youri Tielemans is 10x the player Ruben Cheek is or can be a good upgrade. Let me say this also, I see Bennercer leaving this team for one reason or the other but mainly cus of Pioli.

  3. It is a disastrous transfer agreement that Ac has with Chelsea. To spend 18 million on a player who is in next season, free agent. In comparison, Milan can’t sell any player for now, for any important fee.

  4. Mid made out of Tonali, Tilemanis, Kamada is ridicoulously creative midfield with a lot of shooting power/long shots as well.

      1. Pioli will become Guardiola and we will win via 80% possession and outscoring our opposition by a multiple of 3 every game.

Comments are closed

Serie A Standings

Live football scores . Current table, fixtures & results.